one-color microarray-based gene expression analysis (NimbleGen Systems GmbH)
90
Structured Review
NimbleGen Systems GmbH
one-color microarray-based gene expression analysis
One Color Microarray Based Gene Expression Analysis, supplied by NimbleGen Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+datasets/one+color+microarray+based+gene+expression+analysis/pm28779230-45-12-17
Average 90 stars, based on 1 article reviews
One Color Microarray Based Gene Expression Analysis, supplied by NimbleGen Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+datasets/one+color+microarray+based+gene+expression+analysis/pm28779230-45-12-17
Average 90 stars, based on 1 article reviews
one-color microarray-based gene expression analysis - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Labeling:Article Title: Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics. Article Snippet: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) as a serious event has high mortality and medical costs.. Systemic inflammation and immune response are the major factors influencing the outcome and quality of patient with AECOPD.. On basis of identification and validation of AECOPD-specific inflammatory biomarkers, the present study aimed to identify AECOPD-specific immunomodulatory mediators by evaluating dynamic genomic and proteomic profiles of peripheral bloodmononuclear cells (PBMCs) and plasma in patients with AECOPD on day 1, 3, and 10 after the hospital admission, to compare with healthy controls or patients with stable COPD. Hybridization:Article Title: Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics. Article Snippet: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) as a serious event has high mortality and medical costs.. Systemic inflammation and immune response are the major factors influencing the outcome and quality of patient with AECOPD.. On basis of identification and validation of AECOPD-specific inflammatory biomarkers, the present study aimed to identify AECOPD-specific immunomodulatory mediators by evaluating dynamic genomic and proteomic profiles of peripheral bloodmononuclear cells (PBMCs) and plasma in patients with AECOPD on day 1, 3, and 10 after the hospital admission, to compare with healthy controls or patients with stable COPD. Microarray:Article Title: Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics. Article Snippet: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) as a serious event has high mortality and medical costs.. Systemic inflammation and immune response are the major factors influencing the outcome and quality of patient with AECOPD.. On basis of identification and validation of AECOPD-specific inflammatory biomarkers, the present study aimed to identify AECOPD-specific immunomodulatory mediators by evaluating dynamic genomic and proteomic profiles of peripheral bloodmononuclear cells (PBMCs) and plasma in patients with AECOPD on day 1, 3, and 10 after the hospital admission, to compare with healthy controls or patients with stable COPD. Gene Expression:Article Title: Selection of AECOPD-specific immunomodulatory biomarkers by integrating genomics and proteomics with clinical informatics. Article Snippet: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) as a serious event has high mortality and medical costs.. Systemic inflammation and immune response are the major factors influencing the outcome and quality of patient with AECOPD.. On basis of identification and validation of AECOPD-specific inflammatory biomarkers, the present study aimed to identify AECOPD-specific immunomodulatory mediators by evaluating dynamic genomic and proteomic profiles of peripheral bloodmononuclear cells (PBMCs) and plasma in patients with AECOPD on day 1, 3, and 10 after the hospital admission, to compare with healthy controls or patients with stable COPD. |